Literature DB >> 2324821

Simultaneous assessment of left ventricular wall motion and myocardial perfusion with technetium-99m-methoxy isobutyl isonitrile at stress and rest in patients with angina: comparison with thallium-201 SPECT.

J Villanueva-Meyer1, I Mena, K A Narahara.   

Abstract

The newly developed technetium-99m (99mTc) isonitriles can be used for the simultaneous evaluation of ventricular function and myocardial perfusion. We compared technetium-99m hexakis-2-methoxy isobutyl isonitrile [( 99mTc] MIBI) derived first-pass left ventricular wall motion at stress and rest with simultaneous myocardial perfusion defined by [99mTc]MIBI SPECT. These results were then compared with 201TI SPECT. We examined 28 patients with coronary artery disease; 25 had a previous myocardial infarction. We found concordance between segmental wall motion and myocardial perfusion imaging in defining normal, ischemic, and infarcted myocardium in 68% and 69% of segments using [99mTc]MIBI and 201TI respectively. The best agreement between wall motion and myocardial perfusion was seen in the inferior wall, while most of the discrepancies were found at the apex. Agreement between [99mTc]MIBI and 201TI SPECT myocardial perfusion was seen in 93% of segments. Technetium-99m-MIBI appears to be an ideal radiopharmaceutical for the simultaneous evaluation of ventricular function and myocardial perfusion during stress and at rest.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324821

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  Measurement of ventricular function with radionuclide techniques.

Authors:  Kim A Williams
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

2.  Gated SPECT imaging: increasing the armamentarium of nuclear cardiology.

Authors:  G V Heller
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

3.  Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease.

Authors:  J F Verzijlbergen; A H Zwinderman; C A Ascoop; E E van der Wall; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1996-05

4.  Gated planar technetium 99m-labeled sestamibi myocardial perfusion image inversion for quantitative scintigraphic assessment of left ventricular function.

Authors:  K A Williams; L A Taillon
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

5.  Simultaneous perfusion/function imaging.

Authors:  D S Berman; G Germano; H Kiat; J Friedman
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

6.  Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography.

Authors:  B Benari; H Kiat; J Erel; M Hyun; F P Wang; C Williams; J D Friedman; G Germano; K F Van Train; D Berman
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

Review 7.  Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?

Authors:  B Caner; G A Beller
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

8.  Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration.

Authors:  A Peix; A López; F Ponce; J Morales; A R de la Vega; C S Chesa; A M Maltas; D García-Barreto
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

9.  Amplitude analysis of stress technetium-99m methoxy isobutylisonitrile images in coronary artery disease.

Authors:  E E Camargo; F H Hironaka; M C Giorgi; J Soares Júnior; J C Meneguetti; R Abe; C C Robilotta; A C Munhoz; H Checchi; J A Ramirez
Journal:  Eur J Nucl Med       Date:  1992

10.  Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.

Authors:  G Lucignani; G Paolini; C Landoni; M Zuccari; G Paganelli; L Galli; G Di Credico; G Vanoli; C Rossetti; M A Mariani
Journal:  Eur J Nucl Med       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.